SHUKRA PHARMACEUTICALS
|
The Current P/S Ratio of SHUKRA PHARMACEUTICALS is 11.58.
Share Price | ₹101.8 | Dec 20,2024 |
Market Cap | ₹445.8 Cr | |
Sales-TTM | ₹38.5 Cr | TTM-Standalone Results |
Price/Sales | 11.58x | Calculated as Market Cap/Sales |
---|---|---|
Explore Stock Analytics |
Definition & Calculation of PS (Price/Sales) ratio of SHUKRA PHARMACEUTICALS
P/S =
Market Capitalization
/
Sales
or, using per-share numbers:
P/S = Stock Price / Sales Per Share
Current Market Cap [ ₹445.8 Cr] as on Dec 20,2024
(/) Sales [ ₹38.5 Cr] based on TTM-Standalone Results
(=) P/S Ratio [ 11.58x ]
Thus, for SHUKRA PHARMACEUTICALS , the investors are currently willing to pay '11.58 times sales' to own 1 share of the company.
PS Multiples are one of the most widely used valuation multiple in the industry.
P/S ratios can be a reliable benchmark to compare companies with negative earnings or book value.
You may also explore Price to Earnings ratio or Price to Book ratio of SHUKRA PHARMACEUTICALS !
The chart below summarizes the trend in P/S Ratio of SHUKRA PHARMACEUTICALS over the last five years.
Historical PS (Price/Sales) ratio chart of SHUKRA PHARMACEUTICALS
PS Ratio Performance Analysis for SHUKRA PHARMACEUTICALS
- SHUKRA PHARMACEUTICALS 's p/e ratio for fiscal years ending Mar2024 to Mar2020 averaged 1.36x.
- SHUKRA PHARMACEUTICALS 's operated at median p/e ratio of 0.62x from fiscal years ending March 2018 to 2022.
- Looking back at the last 5 fiscal years, SHUKRA PHARMACEUTICALS 's p/e ratio peaked in Mar2024 at 4.79x.
- SHUKRA PHARMACEUTICALS 's p/e ratio hit its five-year low in Mar2023 of 0.31x.
How does SHUKRA PHARMACEUTICALS 's P/S Ratio benchmark against top 10 peers in Pharmaceuticals & Drugs Industry?
Peer Comparison (Pharmaceuticals & Drugs Industry) | Sales (Cr) | PS Ratio | Market Cap (Cr) |
---|---|---|---|
SHUKRA PHARMACEUTICALS | 38.5 | 11.58 | 445.8 |
SUN PHARMACEUTICAL INDUSTRIES LTD | 50,307.7 | 8.63 | 433,920.0 |
CIPLA LTD | 26,512.0 | 4.49 | 118,917.0 |
DR REDDYS LABORATORIES LTD | 30,084.9 | 3.72 | 112,017.0 |
ZYDUS LIFESCIENCES LTD | 21,483.5 | 4.56 | 97,997.1 |
DIVIS LABORATORIES LTD | 8,614.0 | 18.01 | 155,160.0 |
MANKIND PHARMA LTD | 11,018.0 | 10.50 | 115,661.0 |
TORRENT PHARMACEUTICALS LTD | 11,225.0 | 10.35 | 116,231.0 |
LUPIN LTD | 21,431.3 | 4.57 | 97,978.6 |
AUROBINDO PHARMA LTD | 30,295.0 | 2.38 | 72,060.1 |
ABBOTT INDIA LTD | 6,066.1 | 10.03 | 60,853.1 |
Pharmaceuticals & Drugs Industry Benchmark (Top 10) PS Analysis vs SHUKRA PHARMACEUTICALS 's P/S Ratio
Top 10 Industry Peers | PS Ratio |
---|---|
Min industry PS | 2.38x |
Max industry PS | 18.01x |
Median industry PS | 8.63x |
Average industry PS | 8.07x |
You may also like the below Video Courses